Smarter Drug Development with AI-Driven ADMET Insights
At Neoteric365, we know that not every promising drug candidate makes it to market. In fact, over 90% of the planned drug candidates are estimated to fail. That is why ADMET Profiling (Absorption, Distribution, Metabolism, Excretion, and Toxicity) is one of the most crucial undertakings in the process of drug discovery.
As a new-generation tech company, we use Artificial Intelligence (AI) and computational models to predict ADMET properties early in drug development, helping pharmaceutical and biotech firms filter out weak candidates before costly clinical trials.
What is ADMET Profiling?
ADMET profiling evaluates how a drug behaves inside the body, will it be absorbed properly? Will it reach the right tissues? Will it be metabolized safely, or cause toxic effects? Traditional ADMET testing relies heavily on laboratory experiments and animal studies, which are time-consuming and expensive. Our AI-powered ADMET solutions offer a faster, costeffective, and highly accurate alternative.
Our AI-Driven Approach to ADMET Profiling
At Neoteric365, we combine AI technology with our scientific knowledge to evaluate a drug’s ADMET properties before it enters clinical trials. Here’s how we do it:
1. AI-Powered Predictive Modeling
We use machine learning algorithms trained on extensive datasets of drug properties, clinical
trial data, and real-world outcomes to predict:
- Absorption – How well will the drug be absorbed in the body?
- Distribution – Will it reach the right organs and tissues?
- Metabolism – How will the liver and enzymes break it down?
- Excretion – Will it be safely eliminated from the body?
- Toxicity – Does it pose any risks to the liver, heart, or other organs?
2. Virtual Screening for ADMET Optimization
Instead of spending years in the lab, we run in silico (computer-based) simulations to test thousands of molecular structures in just a few hours. This allows us to swiftly pinpoint safe and effective drug candidates.
3. AI-Guided Molecular Design
If a molecule exhibits poor ADMET properties, our AI models recommend chemical modifications to enhance its profile, there by helping researchers in optimizing drug candidates before expensive lab testing.
4. Integration with Wet Lab Data
We work closely with CROs and biotech labs, integrating experimental ADMET data with our AI predictions. This ensures our models stay accurate, reliable, and constantly evolving.
Why ADMET Profiling is Essential
- Reduces Drug Development Costs: Filtering out weak candidates early can save millions in R&D expenses.
- Improves Drug Success Rates: Focusing on the most promising molecules increases the chance of success in clinical trials.
- Accelerates Time-to-Market: AI-driven ADMET analysis facilitates faster drug development, allowing life-saving treatments to reach patients sooner.
- Enhances Drug Safety & Compliance: Conducting early ADMET profiling ensures adherence to regulatory standards (FDA, EMA, etc.) while minimizing the risk of failures in later stages.
Why Choose Neoteric365 for ADMET Profiling?
- AI-First, Science-Driven: Our models integrate advanced machine learning techniques with deep biological knowledge to deliver precise predictions.
- Cost-Effective & Scalable: We offer rapid, in silico ADMET solutions that minimize the need for expensive lab testing.
- Customized for Your Needs: Whether you’re looking for early-stage screening or comprehensive ADMET analysis, we tailor our solutions to fit your research pipeline.
- Built for Collaboration: We partner with biotech startups, CROs, and pharma companies, helping them optimize their drug discovery and development strategies.
Let’s Build Safer, More Effective Drugs Together!
At Neoteric365, we are bringing AI-driven efficiency to ADMET profiling, helping biotech and pharma teams make smarter, data-driven decisions.
Get in touch with us today!
